June 15, 2026 · Form 4 insider transaction
Goodrich Katherine sold 2,954 shares of Tarsus Pharmaceuticals, Inc. at $62.08 per share, a transaction worth $183.4K. The trade was recorded as open-market sale under a pre-scheduled Rule 10b5-1 plan and disclosed on an SEC Form 4, filed 2 days after the transaction.
The sales reported in this Form 4 were effected by an automatic sale pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on February 27, 2026.